Patient Satisfaction: Opportunity for Better Multiple Sclerosis Therapies

Experts in multiple sclerosis discuss overall patient satisfaction with current disease-modifying therapies for multiple sclerosis, highlighting the need for more therapies that stave off decline and disease progression.

EP: 1.Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis

EP: 2.Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression

EP: 3.Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis

EP: 4.Examining Key Unmet Needs in Multiple Sclerosis

Now Viewing

EP: 5.Patient Satisfaction: Opportunity for Better Multiple Sclerosis Therapies

EP: 6.MS Treatment Guidelines: Expert Insights on Updates and Decision-Making

EP: 7.Incorporating a Subcutaneous Novel Therapy into Multiple Sclerosis Treatment

EP: 8.Examining Challenges with Drug Switching and Step Therapy in MS Treatment

EP: 9.Typical Payer Coverage Criteria for Multiple Sclerosis Therapies

1. How is patient satisfaction overall with current disease modifying therapies for MS?

Related Videos

Related Content

Advertisement

July 9th 2024

FDA Approves Roflumilast for Patients 6 Years and Older With Atopic Dermatitis

Brooke McCormick

Today, the FDA approved roflumilast cream 0.15% (Zorvye; Arcutis Biotherapeutics) for the treatment of mild to moderate atopic dermatitis in patients 6 years and older.

May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi

In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.

July 9th 2024

Exercise Therapy Can Reduce Symptoms, Disease Activity in Axial Spondyloarthritis

Rose McNulty

Patients with axial spondyloarthritis who took part in exercise therapy showed improvements in disease activity and symptoms compared with patients who did not, a meta-analysis found.

May 9th 2024

Frameworks for Advancing Health Equity: Urban Health Outreach

Giuliana Grossi

In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.

July 9th 2024

What We’re Reading: Tirzepatide Outperforms Semaglutide; STDs Continue to Rise Among Older Adults; Nearly Half of US Counties Lack Cardiologist

AJMC Staff

More patients achieve significant weight loss with tirzepatide; new data show significant increases in sexually transmitted disease (STD) diagnoses; many individuals in cardiology deserts are left at higher risk of dying from heart disease.

July 9th 2024

Study Finds Patients With Vitiligo at Higher Risk for Rheumatoid Arthritis, Systemic Lupus Erythematosus

Brooke McCormick

Patients with vitiligo have a higher genetic risk of developing rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).

Related Content

Advertisement

July 9th 2024

FDA Approves Roflumilast for Patients 6 Years and Older With Atopic Dermatitis

Brooke McCormick

Today, the FDA approved roflumilast cream 0.15% (Zorvye; Arcutis Biotherapeutics) for the treatment of mild to moderate atopic dermatitis in patients 6 years and older.

May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi

In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.

July 9th 2024

Exercise Therapy Can Reduce Symptoms, Disease Activity in Axial Spondyloarthritis

Rose McNulty

Patients with axial spondyloarthritis who took part in exercise therapy showed improvements in disease activity and symptoms compared with patients who did not, a meta-analysis found.

May 9th 2024

Frameworks for Advancing Health Equity: Urban Health Outreach

Giuliana Grossi

In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.

July 9th 2024

What We’re Reading: Tirzepatide Outperforms Semaglutide; STDs Continue to Rise Among Older Adults; Nearly Half of US Counties Lack Cardiologist

AJMC Staff

More patients achieve significant weight loss with tirzepatide; new data show significant increases in sexually transmitted disease (STD) diagnoses; many individuals in cardiology deserts are left at higher risk of dying from heart disease.

July 9th 2024

Study Finds Patients With Vitiligo at Higher Risk for Rheumatoid Arthritis, Systemic Lupus Erythematosus

Brooke McCormick

Patients with vitiligo have a higher genetic risk of developing rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).